Background Numerous studies have viewed the benefits of different nootropic drugs such as for example Ginkgo biloba extract (EGb761?; Tanakan?) and piracetam (Nootropyl?) on age-related cognitive decrease often resulting in inconclusive outcomes due to little test sizes or inadequate follow-up duration. results were in opposing directions: the EGb761? group dropped significantly less than the neither… Continue reading Background Numerous studies have viewed the benefits of different nootropic drugs